The year 2017 might be coming to a close, but research continues to ramp up at Children’s Hospital of Philadelphia, with exciting developments in the fields of brain science, hemophilia, gene therapy, and more. In this week’s roundup of headlines, we take a look at remarkable reports from CHOP and Penn Medicine about the brain’s ability to reorganize itself after limb amputation, the first U.S. effort to observe the use of medical cannabis for children with autism, and exciting innovations to improve sickle cell disease treatment presented at the 59th American Society of Hematology Annual Meeting and Exposition. Read on to discover more about these brilliant breakthroughs.
Category Archive: Division of Clinical Pharmacology and Therapeutics
Peter C. Adamson, MD, a pediatric oncologist and leading scientist at The Children’s Hospital of Philadelphia, and a professor of Pediatrics and Pharmacology at the Perelman School of Medicine at the University of Pennsylvania, has been appointed by President Obama to the National Cancer Advisory Board.